. Author manuscript; available in PMC: 2013 Nov 6.

Published in final edited form as: Am J Surg. 2011 Apr 7;202(4):10.1016/j.amjsurg.2011.02.004. doi: 10.1016/j.amjsurg.2011.02.004

Table 1.

Operative and perfusion data for patients undergoing CS and HIPEC for PSD of ovarian malignancies

Variable	n	Median	Range
Surgery time (min)	44	472.5	270.0–1,034.0
Carboplatin dose (mg)	19	1,000.0	500.0–2,136.0
Mitomycin C dose (mg)	32	30.0	30.0–40.0
Perfusion time (min)	51	98.0	60.0–135.0
Inflow temperature (°C)	40	40.8	38.5–42.0
Outflow temperature (°C)	46	39.6	36.9–42.0
Estimated blood loss (mL)	41	450.0	50.0–2,000.0

CS = cytoreductive surgery; HIPEC = hyperthermic intraperitoneal chemotherapy; PSD = peritoneal surface dissemination.